| Adam H Feldman, MD | |
|
301 S 7th Ave, Suite 2020, West Reading, PA 19611-1410 | |
| (610) 375-6565 | |
| (610) 375-2065 |
| Full Name | Adam H Feldman |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 32 Years |
| Location | 301 S 7th Ave, West Reading, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457331480 | NPI | - | NPPES |
| 001751960 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD-054494-L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reading Hospital | West reading, PA | Hospital |
| Pottstown Hospital | Pottstown, PA | Hospital |
| Phoenixville Hospital | Phoenixville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Phoenixville Clinic Company Llc | 5799796850 | 108 |
| Tower Health Medical Group | 7618889213 | 577 |
News Archive
Kun Run Biotechnology, Inc., a leading bio-pharmaceutical company in China focusing on manufacturing and sales of peptide-based and small molecule drugs, today announced that they have obtained the manufacturing approval for Entecavir from the China State Food and Drug Administration (SFDA).
Researchers at Rush University Medical Center have identified a key immunological defense reaction to the metals in joint replacement devices, leading to loosening of the components and early failure.
The U.S. Government has proposed major changes in the rules covering research involving human subjects. Officials believe this would strengthen protections while reducing red tape that can impede studies. The experts cited vastly altered research climate as reasons for these recommendations. New features include genomics studies using patients' DNA samples, the use of the Internet and a growing reliance on studies that take place at many sites at once. The new rules cover topics like the informed consent that research participants must provide and the institutional review boards that oversee research at universities and hospitals.
A team of University of Kentucky researchers has identified the roles that herpes simplex virus type 1 (HSV-1) proteins play during the invasion of cells and the formation of skin lesions known as cold sores and fever blisters.
› Verified 9 days ago
| Entity Name | Tower Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609291350 PECOS PAC ID: 7618889213 Enrollment ID: O20040311000072 |
News Archive
Kun Run Biotechnology, Inc., a leading bio-pharmaceutical company in China focusing on manufacturing and sales of peptide-based and small molecule drugs, today announced that they have obtained the manufacturing approval for Entecavir from the China State Food and Drug Administration (SFDA).
Researchers at Rush University Medical Center have identified a key immunological defense reaction to the metals in joint replacement devices, leading to loosening of the components and early failure.
The U.S. Government has proposed major changes in the rules covering research involving human subjects. Officials believe this would strengthen protections while reducing red tape that can impede studies. The experts cited vastly altered research climate as reasons for these recommendations. New features include genomics studies using patients' DNA samples, the use of the Internet and a growing reliance on studies that take place at many sites at once. The new rules cover topics like the informed consent that research participants must provide and the institutional review boards that oversee research at universities and hospitals.
A team of University of Kentucky researchers has identified the roles that herpes simplex virus type 1 (HSV-1) proteins play during the invasion of cells and the formation of skin lesions known as cold sores and fever blisters.
› Verified 9 days ago
| Entity Name | Phoenixville Clinic Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891866182 PECOS PAC ID: 5799796850 Enrollment ID: O20060606000128 |
News Archive
Kun Run Biotechnology, Inc., a leading bio-pharmaceutical company in China focusing on manufacturing and sales of peptide-based and small molecule drugs, today announced that they have obtained the manufacturing approval for Entecavir from the China State Food and Drug Administration (SFDA).
Researchers at Rush University Medical Center have identified a key immunological defense reaction to the metals in joint replacement devices, leading to loosening of the components and early failure.
The U.S. Government has proposed major changes in the rules covering research involving human subjects. Officials believe this would strengthen protections while reducing red tape that can impede studies. The experts cited vastly altered research climate as reasons for these recommendations. New features include genomics studies using patients' DNA samples, the use of the Internet and a growing reliance on studies that take place at many sites at once. The new rules cover topics like the informed consent that research participants must provide and the institutional review boards that oversee research at universities and hospitals.
A team of University of Kentucky researchers has identified the roles that herpes simplex virus type 1 (HSV-1) proteins play during the invasion of cells and the formation of skin lesions known as cold sores and fever blisters.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam H Feldman, MD Po Box 13579, Reading, PA 19612-3579 Ph: (484) 628-0796 | Adam H Feldman, MD 301 S 7th Ave, Suite 2020, West Reading, PA 19611-1410 Ph: (610) 375-6565 |
News Archive
Kun Run Biotechnology, Inc., a leading bio-pharmaceutical company in China focusing on manufacturing and sales of peptide-based and small molecule drugs, today announced that they have obtained the manufacturing approval for Entecavir from the China State Food and Drug Administration (SFDA).
Researchers at Rush University Medical Center have identified a key immunological defense reaction to the metals in joint replacement devices, leading to loosening of the components and early failure.
The U.S. Government has proposed major changes in the rules covering research involving human subjects. Officials believe this would strengthen protections while reducing red tape that can impede studies. The experts cited vastly altered research climate as reasons for these recommendations. New features include genomics studies using patients' DNA samples, the use of the Internet and a growing reliance on studies that take place at many sites at once. The new rules cover topics like the informed consent that research participants must provide and the institutional review boards that oversee research at universities and hospitals.
A team of University of Kentucky researchers has identified the roles that herpes simplex virus type 1 (HSV-1) proteins play during the invasion of cells and the formation of skin lesions known as cold sores and fever blisters.
› Verified 9 days ago
Ankush Lahoti, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave, Suite 2020, West Reading, PA 19611 Phone: 610-375-6565 Fax: 610-375-2065 | |
Tayyab Ali Waheed, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8640 Fax: 484-628-9003 | |
Nyein Yu, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-5455 | |
Richard Loynd, D.O. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 6th Avenue And Spruce Street, West Reading, PA 19611 Phone: 484-628-8640 Fax: 484-628-9003 | |
Krysta Brown, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave Ste 340, West Reading, PA 19611 Phone: 484-628-8640 Fax: 484-628-9003 | |
Niranjan Tachamo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-5455 | |
Earl J Hope, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave, Suite 2020, West Reading, PA 19611 Phone: 610-375-6565 Fax: 610-375-2065 |